Clinical Trials on Mycosis; Opportunistic
Total 7574 results
-
Merck Sharp & Dohme LLCCompleted
-
Islamia University of BahawalpurCompleted
-
Heidelberg UniversityCompletedInvasive AspergillosisAustria, Germany
-
F2G Biotech GmbHQuotient ClinicalWithdrawn
-
Astellas Pharma China, Inc.TerminatedInvasive AspergillosisChina
-
Royal Brisbane and Women's HospitalThe University of QueenslandCompletedSystemic Fungal Infections
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UMC UtrechtCompletedInvasive AspergillosisNetherlands
-
Universitaire Ziekenhuizen KU LeuvenUnknown
-
F2G Biotech GmbHQuotient ClinicalWithdrawnInvasive Aspergillosis
-
Chulalongkorn UniversityUnknownFungal Infection | VoriconazoleThailand
-
ANRS, Emerging Infectious DiseasesUnknown
-
F2G Biotech GmbHQuotient ClinicalCompleted
-
F2G Biotech GmbHHammersmith Medicines ResearchCompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHSimbec ResearchCompletedInvasive AspergillosisUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...CompletedInvasive AspergillosisSpain
-
University of CologneCompletedInvasive AspergillosisGermany, Belgium
-
Michael Cohen-WolkowiezCompleted
-
Seoul National University HospitalCompletedInvasive AspergillosisKorea, Republic of
-
Sichuan Provincial People's HospitalNot yet recruiting
-
Owlstone LtdRecruiting
-
Bart RijndersRecruiting
-
Mundipharma Research LimitedRecruitingInvasive Fungal InfectionsSpain, United Kingdom, Germany
-
Erasmus Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Stichting...TerminatedInvasive AspergillosisBelgium, Netherlands
-
National Taiwan University HospitalNational Science Council, TaiwanCompletedInvasive Fungal InfectionsTaiwan
-
F2G Biotech GmbHPRA Health SciencesCompletedInvasive Fungal InfectionsNetherlands
-
F2G Biotech GmbHCelerion LtdCompletedInvasive AspergillosisUnited Kingdom
-
National Taiwan University HospitalNational Health Research Institutes, TaiwanUnknown
-
F2G Biotech GmbHSimbec-Orion GroupCompleted
-
Merck Sharp & Dohme LLCWithdrawn
-
University of CopenhagenCompleted
-
Astellas Pharma IncTerminatedInvasive AspergillosisPoland, Belgium, Spain, France, Germany, Colombia, Brazil, Argentina, Hungary, Czech Republic, Croatia, Italy
-
Bayside HealthNational Health and Medical Research Council, AustraliaCompleted
-
PfizerCompletedNon-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IVSerious Fungal Infections
-
PfizerCompleted
-
Astellas Pharma IncTerminatedComparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICUInvasive Fungal InfectionsUnited States, Canada
-
Southeast University, ChinaRecruitingInvasive AspergillosisChina
-
PfizerRecruitingAspergillosis | MucormycosisKorea, Republic of
-
University Hospital, Clermont-FerrandCompletedMicrosporidiosis IntestinalFrance, Guadeloupe
-
National Cancer Institute (NCI)CompletedFungus DiseaseUnited States
-
Merck Sharp & Dohme LLCApproved for marketing
-
F2G Biotech GmbHCovanceCompletedInvasive AspergillosisUnited Kingdom
-
Bayside HealthMerck Sharp & Dohme LLCUnknownFungal InfectionAustralia
-
F2G Biotech GmbHBio-Kinetic Europe, Ltd.WithdrawnInvasive Aspergillosis
-
PfizerTerminatedInvasive AspergillosisSpain, United States, Singapore, Canada, Czechia, Netherlands, Poland, Thailand
-
F2G Biotech GmbHSimbecRresearch Ltd.CompletedInvasive AspergillosisUnited Kingdom
-
F2G Biotech GmbHHammersmith Medicines ResearchCompleted
-
Seoul St. Mary's HospitalUnknown
-
Hospital Universitario Evangelico de CuritibaUnknownInvasive Fungal Infections
-
Gilead SciencesCompletedInvasive AspergillosisFrance